The prevalence of chronic diseases in China has increased rapidly in recent decades.
Although the management rate of chronic diseases has improved, there is still no unified …

With one-fifth of the world's total population, China's prevention and control of cardiovascular
disease (CVD) may affect the success of worldwide efforts to achieve sustainable CVD …

Importance Cardiovascular disease (CVD) remains the top cause of death in China. To our
knowledge, no consistent and comparable assessments of CVD burden have been …

Aims There are limited contemporary data on the presentation, management, and outcomes
of acute coronary syndrome (ACS) admissions in India. We aimed to develop a prospective …

Background The treatment of many chronic illnesses involves long-term pharmaceutical
therapy, but it is an ongoing challenge to find effective ways to improve medication …

More than 4.2 billion inhabitants populate the Asia-Pacific region. Acute coronary syndrome
(ACS) is now a major cause of death and disability in this region with in-hospital mortality …

Background Poor adherence to long-term therapies is a public health concern that affects all
populations. Little is known about the context of adherence in chronic diseases for the …

Background: Japanese patients have been at low risk for cardiovascular events compared
with Western countries, but the data regarding current treatment status and rate of …

Background Acute myocardial infarction (AMI) has become a major cause of hospitalization
and mortality in China. There has been limited data to date available to characterize AMI …

Backgrounds The disparity between ST-segment elevation myocardial infarction (STEMI)
and non-STEMI (NSTEMI) remains controversial. We compared clinical outcomes and …